Mecamylamine inhibits the α7nAChR/NF-ĸB p100/p52 pathway, promotes apoptosis, and disrupts the anti-inflammatory effect in macrophages, potentially influencing the treatment of COAD [55]. The gene discussed is CHRNA7; the disease is colon adenocarcinoma.